Case: Patents/Obviousness (P.T.A.B.)

The Patent Trial and Appeal Board determined that challenged claims of Olink Proteomics AB’s patent that relates to methods for detecting functional interactions between molecules of interest aren’t unpatentable as obvious over prior art, in an inter partes review by Alamar Biosciences Inc. The board said the challenged claims aren’t obvious over various combinations of prior art, including prior art that teaches a reaction discovery approach that uses DNA-templated organic synthesis and in vitro selection to simultaneously evaluate many combinations of different substrates for bond-forming reactions in a single solution, and that the use of self-assembling libraries of organic ...